Ocrelizumab extended dosing in Primary Progressive Multiple Sclerosis during the COVID-19 pandemic: a multicenter experience

被引：0
|
作者：
D'Amico, E. [1 ]
Avolio, C. [1 ]
Lus, G. [2 ]
Bonavita, S. [3 ]
Ferraro, D. [4 ]
Callari, G. [5 ]
Barone, S. [6 ]
Patti, F. [7 ]
Granella, F. [8 ]
Zanghi, A. [9 ]
机构：
[1] Univ Foggia, Foggia, Italy
[2] Univ Campania Luigi Vanvitelli, Naples, Italy
[3] Univ Naples Federico II, Naples, Italy
[4] Univ Modena, Modena, Italy
[5] Irccs Cefalu, Cefalu, Italy
[6] Univ Catanzaro, Catanzaro, Italy
[7] Uni Catania, Catania, Italy
[8] Univ Parma, Parma, Italy
[9] Sant Elia Hosp, Caltanissetta, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1246
引用
下载
收藏
页码：1007 / 1008
页数：2
相关论文
共 50 条
  • [31] Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectiveness
    Barun, Barbara
    Gabelic, Tereza
    Adamec, Ivan
    Babic, Antonija
    Lalic, Hrvoje
    Batinic, Drago
    Skoric, Magdalena Krbot
    Habek, Mario
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
  • [32] Extended vs standard interval dose in Ocrelizumab treated MS patients during COVID-19 pandemic: an Italian experience
    Zanghi, A.
    Inglese, M.
    Ferraro, D.
    Lus, G.
    Bonavita, S.
    Callari, G.
    Valentino, P.
    Granella, F.
    D'Amico, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 348 - 348
  • [33] COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
    Buttari, Fabio
    Bruno, Antonio
    Dolcetti, Ettore
    Azzolini, Federica
    Bellantonio, Paolo
    Centonze, Diego
    Fantozzi, Roberta
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [34] COVID-19 and multiple sclerosis: a thematic analysis of the unique experiences of people with multiple sclerosis during the COVID-19 pandemic
    Simcock-Davies, A.
    Da Silva, A.
    Craig, E. M.
    Middleton, R. M.
    Nicholas, R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 686 - 687
  • [35] COVID-19 Vaccine Failure in a Patient with Multiple Sclerosis on Ocrelizumab
    Chilimuri, Sridhar
    Mantri, Nikhitha
    Gongati, Sudharsan
    Zahid, Maleeha
    Sun, Haozhe
    VACCINES, 2021, 9 (03) : 1 - 3
  • [36] COVID-19 in ocrelizumab-treated people with multiple sclerosis
    Hughes, Richard
    Whitley, Louise
    Fitovski, Kocho
    Schneble, Hans-Martin
    Muros, Erwan
    Sauter, Annette
    Craveiro, Licinio
    Dillon, Paul
    Bonati, Ulrike
    Jessop, Nikki
    Pedotti, Rosetta
    Koendgen, Harold
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
  • [37] Multiple sclerosis during COVID-19 pandemic in Santiago, chile
    Guevara, C.
    Villa, E.
    Cifuentes, M.
    Martinez, M.
    Garrido, C.
    Diaz, V.
    Silva-Rosas, C.
    Naves, R.
    De Grazia, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 53 - 53
  • [38] Vaccination in multiple sclerosis patients during the COVID-19 pandemic
    Brola, Waldemar
    Bielecka, Ewa
    AKTUALNOSCI NEUROLOGICZNE, 2021, 21 (03): : 137 - 142
  • [39] The COVID-19 Pandemic Experience in Multiple Sclerosis: The Good, the Bad and the Neutral
    Morris-Bankole, Hannah
    Ho, Aileen K.
    NEUROLOGY AND THERAPY, 2021, 10 (01) : 279 - 291
  • [40] Commentary COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile
    Ciampi, Ethel
    Uribe-San-Martin, Reinaldo
    Carcamo, Claudia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
12345